Ministry of AYUSH has introduced new Central Sector scheme for promoting pharmacovigilance of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) Drugs. Prime objective of the scheme is to develop the culture of documenting adverse effects and undertake safety monitoring of Ayurveda, Siddha, Unani and Homoeopathy drugs and surveillance of misleading advertisements appearing in the print and electronic media. The Standing Finance Committee (SFC) chaired by Secretary (AYUSH) approved the scheme on 1st November, 2017 and thereafter it was rolled out for implementation in the country near the end of financial year 2017-18.
The World Health Organization and health partners are appealing for US$ 43.5 million to provide life-saving interventions for 388 000 people inside Libya affected by ongoing conflict.
The fourth Conference of AYUSH/Health Ministers of States/UTs was inaugurated by the Minister of State for AYUSH (Independent Charge) Shri Shripad Yesso Naik in New Delhi today. The day long conference was organized by the Ministry of AYUSH to provide an opportunity to States/UT to interact with each other for the development of AYUSH sector. The conference was attended by AYUSH/Health Ministers/Secretaries and officials from 29 States/UTs; senior officials of AYUSH Ministry and representatives of AYUSH organizations.
Hyperglycemia, or increased glucose, is common in patients with acute ischemic stroke and is associated with worse outcomes compared to normal glucose levels. Doctors all over the world have debated whether intensive glucose management, which requires the use of IV insulin to bring blood sugar levels down to 80-130 mg/dL, or standard glucose control using insulin shots, which aims to get glucose below 180 mg/dL, lead to better outcomes after stroke. Primary results from the Stroke Hyperglycemia Insulin Network Effort (SHINE) study, a large, multisite clinical study provide a clear answer to that question.
In a high powered meeting with senior officers of the Health Ministry, Ms Preeti Sudan, Secretary (HFW) reviewed the state of preparedness and action taken to deal with H1N1 influenza cases, here today. Additional Secretary (Health) Shri Sanjeeva Kumar, DCGI Dr S Reddy, Directors and Senior Officials from NCDC and representatives from EMR were also present in the meeting.
As per information of the Botanical Survey of India (BSI), an organization under Ministry of Environment, Forests & Climate Change estimated more than 8,000 species of medicinal plants are found in India.
The Ministry of AYUSH is organising State AYUSH and Health Ministers Conference on 6-2-2019 at New Delhi. The AYUSH /Health Ministers along with senior Officers from all the State and UT Government have been invited to participate in deliberation related to issues concerning AYUSH Sector.
The NPPA has fixed the retail price of 29 formulations under Drugs Price Control Order (DPCO), 2013 through a notification dated 25 January 2019.
Minister of State for Road Transport and Highways, Shipping and Chemicals and Fertilizers, Shri Mansukh L. Mandaviya, while giving a written reply to a question in Rajya Sabha today, stated that as on 31.12.2018, 4677 ‘Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana’ (PMBJP) Kendras are functional in 35 States/UTs of the country.
Central Government recognised that the use of the drug Buclizine as appetite stimulant for human use is not rational and due to lack of clinical trials Government prohibited the manufacture, sale and distribution of Buclizine for the indication “as appetite stimulant”.